These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33211271)

  • 1. Naloxone Diminishes the Virulence and Modifies the Cellular Immune Responses of BALB/c Mice Infected with Leishmania major.
    Alimohammadian MH; Riazi-Rad F; Asadi-Tat M; Darabi S; Darabi H; Khaze V; Bahrami F; Ajdary S
    Acta Parasitol; 2021 Jun; 66(2):517-523. PubMed ID: 33211271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone Effects Against Cutaneous Leishmaniasis Caused by
    Azizi H; Mahdavinik E; Hataminejad M; Khamesipour A; Montazeri S
    Infect Disord Drug Targets; 2023; 23(6):e020623217598. PubMed ID: 37278044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses.
    Nabors GS; Farrell JP
    Infect Immun; 1994 Dec; 62(12):5498-504. PubMed ID: 7960131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The opioid antagonist naloxone inhibits Leishmania major infection in BALB/c mice.
    Karaji AG; Hamzavi Y
    Exp Parasitol; 2012 Jan; 130(1):73-7. PubMed ID: 22019408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
    Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
    Front Immunol; 2018; 9():79. PubMed ID: 29459858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of Interleukin-4 Receptor Alpha-Responsive Keratinocytes in BALB/c Mice Does Not Alter Susceptibility to Cutaneous Leishmaniasis.
    Govender M; Hurdayal R; Martinez-Salazar B; Gqada K; Pillay S; Gcanga L; Passelli K; Nieuwenhuizen NE; Tacchini-Cottier F; Guler R; Brombacher F
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30275010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
    von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
    Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis.
    Badirzadeh A; Heidari-Kharaji M; Fallah-Omrani V; Dabiri H; Araghi A; Salimi Chirani A
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007843. PubMed ID: 31929528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT6 Mediates Footpad Immunopathology in the Absence of IL-12p40 Following Infection of Susceptible BALB/c Mice With
    Kauffmann F; Meert E; de Jonge K; Elkrim Y; Hanot Mambres D; Denis O; Muraille E; Magez S; De Trez C
    Front Immunol; 2018; 9():503. PubMed ID: 29593739
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the long-term and short-term protection in mouse model of Leishmania major infection following vaccination with Live Iranian Lizard Leishmania mixed with chitin microparticles.
    Noroozbeygi M; Keshavarzian N; Haji Molla Hoseini M; Haghdoust S; Yeganeh F
    Parasite Immunol; 2024 Jan; 46(1):e13018. PubMed ID: 37987175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response.
    Muraille E; De Trez C; Brait M; De Baetselier P; Leo O; Carlier Y
    J Immunol; 2003 Apr; 170(8):4237-41. PubMed ID: 12682257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to Leishmania major in IL-4 transgenic mice is not correlated with the lack of a Th1 immune response.
    Erb KJ; Blank C; Moll H
    Immunol Cell Biol; 1996 Jun; 74(3):239-44. PubMed ID: 8799723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model.
    Rostamian M; Jafari D; Abolghazi M; Farahani H; Niknam HM
    Parasitol Res; 2018 Sep; 117(9):2949-2956. PubMed ID: 29978420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice.
    Salari S; Sharifi I; Keyhani AR; Ghasemi Nejad Almani P
    Parasit Vectors; 2020 Aug; 13(1):415. PubMed ID: 32787908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major.
    Tacchini-Cottier F; Zweifel C; Belkaid Y; Mukankundiye C; Vasei M; Launois P; Milon G; Louis JA
    J Immunol; 2000 Sep; 165(5):2628-36. PubMed ID: 10946291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major.
    Tuladhar R; Oghumu S; Dong R; Peterson A; Sharpe AH; Satoskar AR
    Exp Parasitol; 2015 Jan; 148():49-55. PubMed ID: 25447125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
    Li J; Nolan TJ; Farrell JP
    Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with synthetic lipophilic tyrosyl ester controls Leishmania major infection by reducing parasite load in BALB/c mice.
    Sghaier RM; Aissa I; Attia H; Bali A; Leon Martinez PA; Mkannez G; Guerfali FZ; Gargouri Y; Laouini D
    Parasitology; 2016 Oct; 143(12):1615-21. PubMed ID: 27312247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeic acid combined with autoclaved Leishmania major boosted the protection of infected BALB/c mice by enhancing IgG2 production, IFN-γ/TGF-β and iNO synthase/arginase1 ratios, and the death of infected phagocytes.
    Belkhelfa-Slimani R; Djerdjouri B
    Inflammopharmacology; 2018 Apr; 26(2):621-634. PubMed ID: 28988279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.